173 related articles for article (PubMed ID: 24265950)
1. Epidemiology and clinical features of bloodstream infections in hematology wards: one year experience at the catholic blood and marrow transplantation center.
Kwon JC; Kim SH; Choi JK; Cho SY; Park YJ; Park SH; Choi SM; Lee DG; Choi JH; Yoo JH
Infect Chemother; 2013 Mar; 45(1):51-61. PubMed ID: 24265950
[TBL] [Abstract][Full Text] [Related]
2. Bloodstream Infections in Patients with Hematologic Diseases: Causative Organisms and Factors Associated with Resistance.
Choi H; Ahn H; Lee R; Cho SY; Lee DG
Infect Chemother; 2022 Jun; 54(2):340-352. PubMed ID: 35794719
[TBL] [Abstract][Full Text] [Related]
3. Bloodstream infections in adult patients with malignancy, epidemiology, microbiology, and risk factors associated with mortality and multi-drug resistance.
Amanati A; Sajedianfard S; Khajeh S; Ghasempour S; Mehrangiz S; Nematolahi S; Shahhosein Z
BMC Infect Dis; 2021 Jul; 21(1):636. PubMed ID: 34215207
[TBL] [Abstract][Full Text] [Related]
4. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
5. Bloodstream infections in neutropenic patients with haematological malignancies.
Carvalho AS; Lagana D; Catford J; Shaw D; Bak N
Infect Dis Health; 2020 Feb; 25(1):22-29. PubMed ID: 31586572
[TBL] [Abstract][Full Text] [Related]
6. Nosocomial blood stream infection in intensive care units at Assiut University Hospitals (Upper Egypt) with special reference to extended spectrum beta-lactamase producing organisms.
Ahmed SH; Daef EA; Badary MS; Mahmoud MA; Abd-Elsayed AA
BMC Res Notes; 2009 May; 2():76. PubMed ID: 19419535
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and microbiology of Gram-positive bloodstream infections in a tertiary-care hospital in Beijing, China: a 6-year retrospective study.
Zhu Q; Yue Y; Zhu L; Cui J; Zhu M; Chen L; Yang Z; Liang Z
Antimicrob Resist Infect Control; 2018; 7():107. PubMed ID: 30202520
[TBL] [Abstract][Full Text] [Related]
8. Characteristics and Outcomes of Bloodstream Infections in a Tertiary-Care Pediatric Hematology-Oncology Unit: A 10-Year Study.
Mattei D; Baretta V; Mazzariol A; Maccacaro L; Balter R; Zaccaron A; Bonetti E; Chinello M; Vitale V; Caddeo G; Esposto MP; Pezzella V; Gibellini D; Tridello G; Cesaro S
J Clin Med; 2022 Feb; 11(3):. PubMed ID: 35160334
[TBL] [Abstract][Full Text] [Related]
9. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.
Wisplinghoff H; Bischoff T; Tallent SM; Seifert H; Wenzel RP; Edmond MB
Clin Infect Dis; 2004 Aug; 39(3):309-17. PubMed ID: 15306996
[TBL] [Abstract][Full Text] [Related]
10. Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit.
Cordero L; Rau R; Taylor D; Ayers LW
Am J Infect Control; 2004 Jun; 32(4):189-95. PubMed ID: 15175611
[TBL] [Abstract][Full Text] [Related]
11. Clinical and microbiological characteristics of bloodstream infections among patients with haematological malignancies with and without neutropenia at a medical centre in northern Taiwan, 2008-2013.
Chen CY; Tien FM; Sheng WH; Huang SY; Yao M; Tang JL; Tsay W; Tien HF; Hsueh PR
Int J Antimicrob Agents; 2017 Mar; 49(3):272-281. PubMed ID: 28109554
[TBL] [Abstract][Full Text] [Related]
12. Matched case-control analysis of polymicrobial bloodstream infection in a neonatal intensive care unit.
Bizzarro MJ; Dembry LM; Baltimore RS; Gallagher PG
Infect Control Hosp Epidemiol; 2008 Oct; 29(10):914-20. PubMed ID: 18808341
[TBL] [Abstract][Full Text] [Related]
13. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007-2015).
De Angelis G; Fiori B; Menchinelli G; D'Inzeo T; Liotti FM; Morandotti GA; Sanguinetti M; Posteraro B; Spanu T
Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1627-1636. PubMed ID: 29948360
[TBL] [Abstract][Full Text] [Related]
14. Etiology, drug sensitivity profiles and clinical outcome of bloodstream infections: A retrospective study of 784 pediatric patients with hematological and neoplastic diseases.
Chen S; Liu S; Yuan X; Mai H; Lin J; Wen F
Pediatr Hematol Oncol; 2019 Nov; 36(8):482-493. PubMed ID: 31718370
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, resistant pathogens, and causes of early death in cases of bloodstream infection in patients with hematological malignancies from 2012-2019.
Li M; Du M; Li H; Liu D; Liu Y
Infect Med (Beijing); 2022 Mar; 1(1):23-30. PubMed ID: 38074981
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime.
Chopra T; Marchaim D; Johnson PC; Chalana IK; Tamam Z; Mohammed M; Alkatib S; Tansek R; Chaudhry K; Zhao JJ; Pogue JM; Kaye KS
Am J Infect Control; 2015 Jul; 43(7):719-23. PubMed ID: 25934068
[TBL] [Abstract][Full Text] [Related]
17. Bloodstream infections: trends and evolution of incidence and etiology in a 12-year period (2010-2021).
Alonso-Menchén D; Sánchez-Carrillo C; Alcalá L; Soriano-Martín A; Cercenado E; Burillo A; Serrano-Lobo J; Pérez-Latorre L; Muñoz P; Bouza E
Infect Dis (Lond); 2024 Jun; 56(6):441-450. PubMed ID: 38407125
[TBL] [Abstract][Full Text] [Related]
18. A practical update on the epidemiology and risk factors for the emergence and mortality of bloodstream infections from real-world data of 3014 hematological malignancy patients receiving chemotherapy.
Chen S; Lin K; Li Q; Luo X; Xiao M; Chen M; Zhu H; Chen Y; Wu X; Zeng Y; Zhang Y; Ally IH; Xu J; Ren J; Chen Z; Hu J; Yang T
J Cancer; 2021; 12(18):5494-5505. PubMed ID: 34405012
[No Abstract] [Full Text] [Related]
19. Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae.
Scheuerman O; Schechner V; Carmeli Y; Gutiérrez-Gutiérrez B; Calbo E; Almirante B; Viale PL; Oliver A; Ruiz-Garbajosa P; Gasch O; Gozalo M; Pitout J; Akova M; Peña C; Molina J; Hernández-Torres A; Venditti M; Prim N; Origüen J; Bou G; Tacconelli E; Tumbarello M; Hamprecht A; Karaiskos I; de la Calle C; Pérez F; Schwaber MJ; Bermejo J; Lowman W; Hsueh PR; Navarro-San Francisco C; Bonomo RA; Paterson DL; Pascual A; Rodríguez-Baño J;
Infect Control Hosp Epidemiol; 2018 Jun; 39(6):660-667. PubMed ID: 29618394
[TBL] [Abstract][Full Text] [Related]
20. Risk factors and outcomes in non-transplant patients with extended-spectrum beta-lactamase-producing
Xiao T; Yang K; Zhou Y; Zhang S; Ji J; Ying C; Shen P; Xiao Y
Antimicrob Resist Infect Control; 2019; 8():144. PubMed ID: 31467670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
